AIM Immunotech Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AIM Immunotech Inc. (AIM) on September 10, 2026, covering events that occurred on September 3 and September 4, 2026. The company is incorporated in Delaware and its common stock trades on the NYSE American under the symbol "AIM".
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or total debt levels. The primary financial activity reported is a debt-to-equity conversion.
- Debt Converted: Approximately $450,000 of a Promissory Note dated November 18, 2025.
- Equity Issued: 1,921,441 shares of common stock.
- Conversion Price: Approximately $0.234 per share.
- Counterparty: Streeterville Capital, LLC.
Material Changes
The material change reported is the reduction of outstanding debt and the corresponding increase in outstanding common shares through the execution of two Exchange Agreements and Partitioned Promissory Notes. This transaction satisfies a portion of the Promissory Note previously approved by stockholders at a special meeting on July 15, 2026, in accordance with NYSE American Company Guide Sections 713(a) and 713(b).
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure regarding the unregistered sale of equity. The issuance of the Exchange Shares was conducted pursuant to the exemption from registration requirements under Section 3(a)(9) of the Securities Act of 1933, as no commission was paid for soliciting the exchange.
Investor Verification Checklist
- Verify the total outstanding balance of the Promissory Note dated November 18, 2025, to understand the remaining debt obligation.
- Confirm the total number of authorized and outstanding shares post-conversion to assess dilution impact.
- Review the full text of the Exchange Agreement (Exhibit 10.1) for any covenants or conditions attached to the remaining debt.
- Check subsequent filings for any additional conversions or liquidity events related to Streeterville Capital, LLC.